LYRA

LYRA

USD

Lyra Therapeutics Inc. Common Stock

$5.445-0.215 (-3.799%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$5.660

High

$5.660

Low

$5.395

Volume

0.04M

Company Fundamentals

Market Cap

9.0M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.03M

Exchange

NCM

Currency

USD

52-Week Range

Low $3.81Current $5.445High $37.5

Related News

GlobeNewswire

Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study

Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission Positive ENLIGHTEN 2 results highlighted at the AAO-HNS 2025 Annual Meeting WATERTOWN, Mass., Oct. 06, 2025 (GLOBE

View more
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study